Skip to main content

Table 2- Multivariate logistic regression of potential predictors for extensively drug-resistant Acinetobacter baumannii acquisition during the study period

From: The effect of temporary closure and enhanced terminal disinfection using aerosolized hydrogen peroxide of an open-bay intensive care unit on the acquisition of extensively drug-resistant Acinetobacter baumannii

Variables

Odds Ratio (95% Confidence Interval)

P

Wound

3.72 (0.99–13.96)

0.05

Urinary catheter (≥ 5 d)

1.42 (0.42–4.79)

0.58

Mechanical ventilation

4.99 (1.76–14.15)

0.002

CCI score

0

0.71 (0.13–3.98)

0.70

5–6

2.55 (0.96–6.81)

0.06

7–8

0.48 (0.11–2.14)

0.34

XDR-AB contact pressure (≥ 3 d)

9.86 (3.65–26.64)

< 0.0001

CAR use (≥ 4 d)

2.50 (0.43–14.36)

0.31

TZP use

2.86 (0.97–8.46)

0.06

CAR or TZP use (≥ 4 d)

0.58 (0.13–2.68)

0.49

LOS in the ICU (≥ 4 d)

1.29 (0.39–4.30)

0.68

Number of patients staying in the ICU during each numerical week after ETD

Week 6

3.37 (0.89–12.71)

0.07

Week 7

6.47 (1.21–34.50)

0.03

Week 8

0.30 (0.04–2.39)

0.26

Week 9

3.23 (0.59–17.75)

0.18

Week 10

0.12 (0.01–1.03)

0.053

Week 11

9.73 (1.66–57.12)

0.01

Week 12

2.65 (0.49–14.52)

0.26

Week 13

0.14 (0.02–1.24)

0.08

Week 14

14.37 (1.75–118.17)

0.01

Week 15

1.34 (0.11–15.85)

0.82

Week 16

3.33 (0.26–43.02)

0.36

  1. Variables included in the model: Urinary catheter (reference: < 5 d); Mechanical ventilation (reference: no); CCI score; XDR-AB contact pressure (reference: < 3 d); CAR (reference: < 4 d); TZP use (reference: no); CAR or TZP use (reference: < 4 d); LOS in the ICU (Reference: < 4 d); Number of patients staying in the ICU during each numerical week after ETD: Week 6 to Week 16 (reference: no)
  2. KEY = CAR Carbapenems, CCI Charlson Comorbidity Index, d days, ETD Enhanced Terminal Disinfection, ICU Intensive Care Unit, LOS: Length of Stay, TZP Piperacillin/Tazobactam, XDR-AB Extensively-drug resistant Acinetobacter bumannii